ArticleScientific reports2025
Unlocking the daily impact of parkinson's challenges through a comprehensive assessment using the ChulaPD ADL questionnaire.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- What's in a name? reframing advanced Parkinson's disease as a multidimensional state.Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
- Influence of Age on the Effectiveness of Lee Silverman Voice TreatmentGeriatrics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The ChulaPD ADL questionnaire is a meticulously developed tool by experts in Parkinson's disease (PD) and movement disorders, designed to assess functional limitations in daily activities. It comprehensively evaluates 15 key aspects of daily life through 115 items, including 15 for grading limitations and 100 for ADL limitations. Validated in a pilot study with 30 PD participants, the questionnaire demonstrated strong reliability. In a larger cohort of 231 PD patients, it showed moderate to high correlations with age, Hoehn and Yahr score, levodopa equivalent dose, Montreal Cognitive Assessment, and various UPDRS scores, highlighting its effectiveness in capturing disease-related changes. A grading limitation threshold of 13 points or above was particularly effective in identifying postural instability, achieving 81.4% sensitivity and 50.7% specificity, with an area under the curve (AUC) of 0.747. This underscores its utility in reflecting disease progression and its impact on daily functions. The ChulaPD ADL questionnaire is a relevant, reliable, and valid tool for assessing activities of daily living in patients with PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.